Article Type
Article
Changed
Tue, 01/22/2019 - 11:39
Display Headline
Progress in diagnosing and managing cardiac amyloidosis
Author(s)
Mazen Hanna, MD
Chetan Huded, MD
E. Rene Rodriguez, MD
Dermot Phelan, MD
Deborah Kwon, MD
Wael Jaber, MD
Jason Valent, MD
Michael Zhen-Yu Tong, MD, MBA

From the Cleveland Clinic Journal of Medicine

This article has been removed from the website. The article was prepared by the editorial staff based on a transcript of the proceedings of a conference, and errors occurred during this process that were subsequently published. A clarification of the errors will be published in a future issue.

A review of this topic was published in the December 2017 issue of the Journal (Donnelly JP, Hanna M. Cardiac amyloidosis: An update on diagnosis and treatment. Cleve Clin J Med 2017;84[12suppl 3]:12–26). doi:10.3949/ccjm.84.s3.02

Author and Disclosure Information

Mazen Hanna, MD
Co-Director, Amyloidosis Center, Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic

Chetan Huded, MD
Resident Fellow, Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic

E. Rene Rodriguez, MD
Director, Cardiovascular Pathology, Director, Autopsy Pathology, Department of Anatomic Pathology, Cleveland Clinic; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Dermot Phelan, MD
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic

Deborah Kwon, MD
Director of Cardiac MRI Research, Department of Cardiovascular Medicine and Department of Diagnostic Radiology, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Wael Jaber, MD
Department of Cardiovascular Medicine, Heart and Vascular Institute, and Department of Nuclear Medicine, Cleveland Clinic

Jason Valent, MD
Department of Hematology and Medical Oncology Cleveland Clinic

Michael Zhen-Yu Tong, MD, MBA
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic

Address: Mazen Hanna, MD, Department of Cardiovascular Medicine, Heart and Vascular Institute, J3-4, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; hammam@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 86(1)
Publications
Cleveland Clinic Journal of Medicine
Topics
Cardiology
Page Number
29-37
Sections
Medical Grand Rounds
Author(s)
Mazen Hanna, MD
Chetan Huded, MD
E. Rene Rodriguez, MD
Dermot Phelan, MD
Deborah Kwon, MD
Wael Jaber, MD
Jason Valent, MD
Michael Zhen-Yu Tong, MD, MBA
Author(s)
Mazen Hanna, MD
Chetan Huded, MD
E. Rene Rodriguez, MD
Dermot Phelan, MD
Deborah Kwon, MD
Wael Jaber, MD
Jason Valent, MD
Michael Zhen-Yu Tong, MD, MBA
Author and Disclosure Information

Mazen Hanna, MD
Co-Director, Amyloidosis Center, Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic

Chetan Huded, MD
Resident Fellow, Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic

E. Rene Rodriguez, MD
Director, Cardiovascular Pathology, Director, Autopsy Pathology, Department of Anatomic Pathology, Cleveland Clinic; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Dermot Phelan, MD
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic

Deborah Kwon, MD
Director of Cardiac MRI Research, Department of Cardiovascular Medicine and Department of Diagnostic Radiology, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Wael Jaber, MD
Department of Cardiovascular Medicine, Heart and Vascular Institute, and Department of Nuclear Medicine, Cleveland Clinic

Jason Valent, MD
Department of Hematology and Medical Oncology Cleveland Clinic

Michael Zhen-Yu Tong, MD, MBA
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic

Address: Mazen Hanna, MD, Department of Cardiovascular Medicine, Heart and Vascular Institute, J3-4, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; hammam@ccf.org

Author and Disclosure Information

Mazen Hanna, MD
Co-Director, Amyloidosis Center, Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic

Chetan Huded, MD
Resident Fellow, Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic

E. Rene Rodriguez, MD
Director, Cardiovascular Pathology, Director, Autopsy Pathology, Department of Anatomic Pathology, Cleveland Clinic; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Dermot Phelan, MD
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic

Deborah Kwon, MD
Director of Cardiac MRI Research, Department of Cardiovascular Medicine and Department of Diagnostic Radiology, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Wael Jaber, MD
Department of Cardiovascular Medicine, Heart and Vascular Institute, and Department of Nuclear Medicine, Cleveland Clinic

Jason Valent, MD
Department of Hematology and Medical Oncology Cleveland Clinic

Michael Zhen-Yu Tong, MD, MBA
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic

Address: Mazen Hanna, MD, Department of Cardiovascular Medicine, Heart and Vascular Institute, J3-4, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; hammam@ccf.org

From the Cleveland Clinic Journal of Medicine

This article has been removed from the website. The article was prepared by the editorial staff based on a transcript of the proceedings of a conference, and errors occurred during this process that were subsequently published. A clarification of the errors will be published in a future issue.

A review of this topic was published in the December 2017 issue of the Journal (Donnelly JP, Hanna M. Cardiac amyloidosis: An update on diagnosis and treatment. Cleve Clin J Med 2017;84[12suppl 3]:12–26). doi:10.3949/ccjm.84.s3.02

From the Cleveland Clinic Journal of Medicine

This article has been removed from the website. The article was prepared by the editorial staff based on a transcript of the proceedings of a conference, and errors occurred during this process that were subsequently published. A clarification of the errors will be published in a future issue.

A review of this topic was published in the December 2017 issue of the Journal (Donnelly JP, Hanna M. Cardiac amyloidosis: An update on diagnosis and treatment. Cleve Clin J Med 2017;84[12suppl 3]:12–26). doi:10.3949/ccjm.84.s3.02

Issue
Cleveland Clinic Journal of Medicine - 86(1)
Issue
Cleveland Clinic Journal of Medicine - 86(1)
Page Number
29-37
Page Number
29-37
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Topics
Cardiology
Article Type
Article
Display Headline
Progress in diagnosing and managing cardiac amyloidosis
Display Headline
Progress in diagnosing and managing cardiac amyloidosis
Sections
Medical Grand Rounds
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Fri, 01/18/2019 - 16:00
Un-Gate On Date
Fri, 01/18/2019 - 16:00
Use ProPublica
CFC Schedule Remove Status
Fri, 01/18/2019 - 16:00